arrow
P

Patrick Neven

universitair ziekenhuis leuven
H指数:88
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study
2026-06-240
OAAI
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue

抗体偶联药物靶点在乳腺癌转移灶和正常组织死后样本中的表达

2025-12-260
OAAI
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer: Updated Efficacy Results from the phase 3 EMBER-3 trial

Imlunestrant与或不与Abemaciclib联用治疗晚期乳腺癌:来自Ⅲ期EMBER-3试验的更新疗效结果

2025-12-120
OAAI
Personalized ctDNA detection and genomic profiling in the NeoRHEA Study

个性化循环肿瘤DNA检测和基因组分析在NeoRHEA研究中

2025-12-050
OAAI
ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer

ctDNA在转移性乳腺癌患者七种体液中的检测性与代表性

2025-12-020
OAAI
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study

Palbociclib和内分泌疗法减弱早期乳腺癌的适应性抗肿瘤免疫:NeoRHEA 2期研究

2025-11-260
OAAI
Enhancing translational research in metastatic cancer through an open science environment: the UPTIDER experience

通过开放科学环境增强转移性癌症的转化研究:UPTIDER项目经验

2025-11-060
OAAI
Overall Survival with Abemaciclib in Early Breast Cancer

早期乳腺癌中使用Abemaciclib的总体生存率

2025-10-170
OAAI
The role of body mass index at diagnosis in patients with inflammatory breast cancer

炎性乳腺癌患者诊断时体重指数的作用

2025-10-120
OAAI
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology
BREAST
IF7.9
2024-06-014
OAAI